Ultrafine particle deposition and clearance in the healthy and obstructed lung

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 9, 2002, Pages 1240-1247

  Brown, James S ^a   Zeman, Kirby L ^a   Bennett, William D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosols; Chronic obstructive pulmonary disease; Mucociliary clearance

Indexed keywords

CARBON; TECHNETIUM 99M;

ADULT; AEROSOL; AGED; AIR POLLUTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; FEMALE; HUMAN; ISOTOPE LABELING; LIVER; LUNG CLEARANCE; MALE; PARTICULATE MATTER; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; AGED; FEMALE; HUMANS; LIVER; LIVER CIRCULATION; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; PARTICLE SIZE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 0036841884     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200205-399OC     Document Type: Article

References (49)

1. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An association between air pollution and mortality in six US cities. N Engl J Med 1993;329:1753-1759.
2. Pope CA, Dockery DW, Schwartz J. Review of epidemiological evidence of health effects of particulate air pollution. Inhal Toxicol 1995;7:1-18.
3. Ferin J, Oberdorster G, Penny DP. Pulmonary retention of ultrafine and fine particle in rats. Am J Respir Cell Mol Biol 1992;6:535-542.
4. Ferin J. Pulmonary retention and clearance of particles. Toxicol Letters 1994;72:121-125.
5. Churg A. The uptake of mineral particles by pulmonary epithelial cell. Am J Respir Crit Care Med 1996;154:1124-1140.
6. Seaton A, MacNee W, Donaldson K, Godden D. Particulate air pollution and acute health effects. Lancet 1995:345:176-178.
7. Peters A, Doring A, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: A link to mortality? Lancet 1997;349:1582-1587.
8. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997;155:1376-1383.
9. Wilson FJ Jr, Hiller FC, Wilson JD, Bone RC. Quantitative deposition of ultrafine stable particles in the human respiratory tract. J Appl Physiol 1985;58:223-229.
10. Schiller CF, Gebhart J, Heyder J, Rudolf G, Stahlhofen W. Deposition of monodisperse insoluble aerosol particles in the 0.005 to 0.2 μm size range within the human respiratory tract. Ann Occup Hyg 1988;32(Suppl. 1):41-49.
11. Anderson PJ, Wilson JD, Hiller FC. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest 1990;97:1115-1120.
12. Jaques PA, Kim CS. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol 2000;12:715-731.
13. Kim CS, Jaques PA. Respiratory dose of inhaled ultrafine particles in healthy adults. Philos Trans R Soc Lond A 2000;358:2693-2705.
14. Roth C, Scheuch G, Stahlhofen W. Clearance measurements with radioactively labelled ultrafine particles. Ann Occup Hyg 1994;38(Suppl. 1):101-106.
15. Lemb M, Oei TH, Eifert H, Gunther B. Technegas: A study of particle structure, size and distribution. Eur J Nucl Med 1993:20:576-579.
16. Lloyd JJ, Shields RA, Taylor CJ, Lawson RS, James JM, Testra HJ. Technegas and Pertechnegas particle size and distribution. Eur J Nucl Med 1995;22:473-476.
17. Roth C, Kreyling WG, Scheuch G, Busch B, Stahlhofen W. Deposition and clearance of fine particles in the human respiratory tract. Ann Occup Hyg 1997;41(Suppl. 1):503-508.
18. Burch WM, Sullivan PJ, McLaren CJ. Technegas: A new ventilation agent for lung scanning. Nucl Med Commun 1986;7:865-871.
19. Pellegrino R, Biggi A, Papaleo A, Camuzzini G, Rodarte JR, Brusasco V. Regional expiratory flow limitation studied with Technegas in asthma. J Appl Physiol 2001;91:2190-2198.
20. Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;105:411-414.
21. Stahlhofen W, Rudolf G, James AC. Intercomparison of experimental regional aerosol deposition data. J Aerosol Med 1989;2:285-308.
22. Brown JS, Gerrity TR, Bennett WD. Effect of ventilation distribution on aerosol bolus dispersion and recovery. J Appl Physiol 1988;85:2112-2117.
23. Brown JS, Kim CS, Reist PC, Zeman KL, Bennett WD. Generation of radiolabeled "soot-like" ultrafine aerosols suitable for use in human inhalation studies. Aerosol Sci Technol 2000;32:325-337.
24. Bennett WD, Zeman KL, Kim C, Mascarella J. Enhanced deposition of fine particles in COPD patients spontaneously breathing at rest. Inhal Toxicol 1997:19:1-14.
25. Sinclair D, Hoopes GS. A novel form of diffusion battery. Am Ind Hyg Assoc J 1975:36:39-42.
26. Brown JS, Zeman KL, Bennett WD. Regional deposition of coarse particles and ventilation distribution in patients with cystic fibrosis. J Aerosol Med 2001;14:443-454.
27. Smaldone GC, Perry RJ, Bennett WD, Messina MS, Zwang J, Ilowite L. Interpretation of "24 hour lung retention" in studies of mucociliary clearance. J Aerosol Med 1988;1:11-20.
28. Ilowite J, Smaldone GC, Perry RJ, Bennett WD, Foster WM. Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch Environ Health 1989;44:267-273.
29. Smaldone GC, Foster WM, O'Riordan TC, Messina MS, Perry RJ, Langenback EG. Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease. Chest 1993;103:1390-1396.
30. Littel RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute; 1996.
31. Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-Plus. New York: Springer; 2000.
32. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734.
33. Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 1961;84:789-806.
34. Diu CK, Yu CP. Respiratory tract deposition of polydisperse aerosols in humans. Am Ind Hyg Assoc J 1983;44:62-65.
35. Frampton MW, Chalupa D, Morrow PE, Gibb FR, Oberdorster G, Boscia J, Speers DM, Utell MJ. Deposition of inhaled ultrafine carbon particles in resting healthy nonsmoking adults [abstract]. Am J Respir Crit Care Med 2000;161:A257.
36. Bennett WD, Zeman KL. Effect of enhanced supramaximal flows on cough clearance. J Appl Physiol 1994;77:1577-1583.
37. 99mTc-labeled iron oxide aerosols for human lung deposition and clearance studies. Int J Appl Radiat Isot 1980;31:689-694.
38. Scheuch G, Miller W, Sommerer K. Insoluble 99mTc labelled iron oxide for clearance studies. 17th Annual American Association for Aerosol Research Conference. Cincinnati, OH: American Association for Aerosol Research; 1998. p. 268.
39. Monaghan P, Provan I, Murray C, Mackey DWJ, Van der Wall H, Walker BM, Jones PD. An improved radionuclide technique for the detection of altered pulmonary permeability. J Nucl Med 1991;32:1945-1949.
40. Mead J. Contribution of compliance of airways to frequency-dependent behavior of lungs. J Appl Physiol 1969:26:670-673.
41. Suga K, Nishigauchi K, Kume N, Koike S, Takano K, Matsunaga N. Regional ventilation evaluation using dynamic SPET imaging of xenon-133 washout in obstructive lung disease: An initial study. Eur J Nucl Med 1995;22:220-226.
42. Trajan M, Logus JW, Enns EG, Man SFP. Relationship between regional ventilation and aerosol deposition in tidal breathing. Am Rev Respir Dis 1984;130:64-70.
43. Susskind H, Brill AB, Harold WH. Quantitative comparison of regional distributions of inhaled Tc-99m DTPA aerosol and Kr-81m Gas in coal miners' lungs. Am J Physiol Imaging 1986:1:67-76.
44. King GG, Eberl S, Salome CM, Young IH, Woolcock AJ. Differences in airway closure between normal and asthmatic subjects measured with single-photon emission computed tomography and Technegas. Am J Respir Crit Care Med 1998;158:1900-1906.
45. Miller FJ, Anjilvel S, Menache MG, Asgharian B, Gerrity TR. Dosimetric Issues relating to particle toxicity. Inhal Toxicol 1995;7:615-632.
46. Isawa T, Teshima T, Anazawa Y, Miki M, Motomiya M. Technegas for inhalation lung imaging. Nucl Med Commun 1991;12:47-55.
47. Isawa T, Teshima T, Anazawa Y, Miki M, Mahmud AM. Inhalation of pertechnegas: Similar clearance from the lung to that of inhaled pertechnetate aerosol. Nucl Med Commun 1995;16:741-746.
48. Xu JH, Moonen M, Johansson A, Bake B. Dynamics of "Technegas" deposited in the lung. Nucl Med Commun 2001;22:383-387.
49. Scalzetti EM, Gagne GM. The transition from Technegas to Pertechnegas. J Nucl Med 1995;36:267-269.